An orally administered peptide hydrogel disentangles immune-microbiota crosstalk for long-term ulcerative colitis therapy
Tianyu Li, Mengqian Shi, Jintao Shen…·Xuehai Yan
This paper develops an orally administered peptide hydrogel that disrupts immune-microbiota interactions to treat ulcerative colitis, showing improved mucosal integrity and microbiota rebalancing in mice.